@article{2106730defa64225b3735b434fae23a4,
title = "Sip1 regulates the generation of the inner nuclear layer retinal cell lineages in mammals",
abstract = "The transcription factor Sip1 (Zeb2) plays multiple roles during CNS development from early acquisition of neural fate to cortical neurogenesis and gliogenesis. In humans, SIP1 (ZEB2) haploinsufficiency leads to Mowat–Wilson syndrome, a complex congenital anomaly including intellectual disability, epilepsy and Hirschsprung disease. Here we uncover the role of Sip1 in retinogenesis. Somatic deletion of Sip1 from mouse retinal progenitors primarily affects the generation of inner nuclear layer cell types, resulting in complete loss of horizontal cells and reduced numbers of amacrine and bipolar cells, while the number of Muller glia is increased. Molecular analysis places Sip1 downstream of the eye field transcription factor Pax6 and upstream of Ptf1a in the gene network required for generating the horizontal and amacrine lineages. Intriguingly, characterization of differentiation dynamics reveals that Sip1 has a role in promoting the timely differentiation of retinal interneurons, assuring generation of the proper number of the diverse neuronal and glial cell subtypes that constitute the functional retina in mammals.",
keywords = "Differentiation, Neurogenesis, Progenitor, Retina, Retinogenesis, Sip1, Zeb2, Zfhx1b",
author = "Yotam Menuchin-Lasowski and Pazit Oren-Giladi and Qing Xie and Raaya Ezra-Elia and Ron Ofri and Shany Peled-Hajaj and Chen Farhy and Yujiro Higashi and {Van de Putte}, Tom and Hisato Kondoh and Danny Huylebroeck and Ales Cvekl and Ruth Ashery-Padan",
note = "Funding Information: Research in the R.A.-P. laboratory is supported by grants from Israel Science Foundation [228/14], German Israeli Foundation for Scientific Research and Development [I-1128-156.1/201] and BrightFocus Foundation [M2013065]. R.A.-P. and A.C. are supported by United States-Israel Binational Science Foundation [2013016]. A.C. is supported by the National Institutes of Health [R01 EY012200] and an unrestricted grant from Research to Prevent Blindness (RPB) to the Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine. Y.M.-L. is supported by Teva Pharmaceutical Industries Ltd under the Israeli National Network of Excellence in Neuroscience (NNE) established by Teva. Research in the D.H. laboratory is supported by the Research Council of KU Leuven (Onderzoeksraad, KU Leuven) [GOA-11/012], FondsWetenschappelijk Onderzoek - Vlaanderen (FWO-V) [G.0782.14], the Interuniversity Attraction Poles from the Belgian Science Policy Office (Federaal Wetenschapsbeleid) [Belspo IUAP-VII/07], the InfraMouse Grant from the Hercules Foundation (Herculesstichting) [ZW09-03] and start-up funding at Erasmus Medisch Centrum. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. Deposited in PMC for release after 12 months. Publisher Copyright: {\textcopyright} 2016. Published by The Company of Biologists Ltd.",
year = "2016",
month = aug,
day = "1",
doi = "10.1242/dev.136101",
language = "English (US)",
volume = "143",
pages = "2829--2841",
journal = "Development (Cambridge)",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "15",
}